Egaña-Gorroño, L., López-Díez, R., Yepuri, G., Ramirez, L. S., Reverdatto, S., Gugger, P. F., . . . Schmidt, A. M. (2020). Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models. Frontiers in cardiovascular medicine, 7, 37. https://doi.org/10.3389/fcvm.2020.00037
Chicago Style (17th ed.) CitationEgaña-Gorroño, Lander, Raquel López-Díez, Gautham Yepuri, Lisa S. Ramirez, Sergey Reverdatto, Paul F. Gugger, Alexander Shekhtman, Ravichandran Ramasamy, and Ann Marie Schmidt. "Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models." Frontiers in Cardiovascular Medicine 7 (2020): 37. https://doi.org/10.3389/fcvm.2020.00037.
MLA (9th ed.) CitationEgaña-Gorroño, Lander, et al. "Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models." Frontiers in Cardiovascular Medicine, vol. 7, 2020, p. 37, https://doi.org/10.3389/fcvm.2020.00037.